Orlucent Receives FDA Breakthrough Device Designation for Handheld Mole Imaging System

/PRNewswire/ -- Orlucent, Inc., a company focused on clinical assessment of suspicious moles, today announced the U.S. Food and Drug Administration (FDA) has...

Related Keywords

Jeff Christensen ,Catherine Shachaf ,Orlucent Inc ,Drug Administration ,Prnewswire Orlucent Inc ,Breakthrough Device Designation ,Skin Fluorescence Imaging ,Breakthrough Device ,Orlucent System ,Skin Fluorescence Imaging System ,Orlucent ,Nc ,